An α-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes

D. Ly, R. Tohn, B. Rubin, H. Blumenfeld, G. S. Besra, N. Veerapen, S. A. Porcelli, T. L. Delovitch

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'An α-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences